Immuno-Oncology Patient Guide
Scientists worldwide have been studying the role the immune system can play in fighting cancer for several decades. However, it was only recently that immuno-oncology therapies were found that provide lasting anti-cancer benefits to patients who previously had very few treatment options available to them.1-3 These therapies represent a ‘breakthrough’4 in cancer therapy and they have the potential to revolutionise the way we treat many forms of cancer.5 This leaflet aims to help patients understand what these new therapies are, how they differ from existing treatments, and what role they will play in years to come.
Kindly find below ECPC's on-line Guide for Patients on Immuno-Oncology for dissemination in the following 21 languages. This leaflet was developed to help patients understand more about immuno-oncology therapies, a new type of cancer treatment that uses the immune system to fight cancer:
This document has been produced by the European Expert Group on Immuno-Oncology, an independent network composed of patient organisations, cancer specialists, researchers and policymakers from across Europe who are working together to make sure that the most effective of these promising new treatments are made available to patients as quickly as possible.
* ECPC believes that whereas the core document provides important information, it needs to be revised and updated based on current statistics and following the recent developments with regards to research on melanoma. *